Search Results - "Stephenson, Natalie L"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor Suppressor by Antal, Corina E., Hudson, Andrew M., Kang, Emily, Zanca, Ciro, Wirth, Christopher, Stephenson, Natalie L., Trotter, Eleanor W., Gallegos, Lisa L., Miller, Crispin J., Furnari, Frank B., Hunter, Tony, Brognard, John, Newton, Alexandra C.

    Published in Cell (29-01-2015)
    “…Protein kinase C (PKC) isozymes have remained elusive cancer targets despite the unambiguous tumor promoting function of their potent ligands, phorbol esters,…”
    Get full text
    Journal Article
  2. 2

    Direct observation of proteolytic cleavage at the S2 site upon forced unfolding of the Notch negative regulatory region by Stephenson, Natalie L., Avis, Johanna M.

    “…The conserved Notch signaling pathway plays crucial roles in developing and self-renewing tissues. Notch is activated upon ligand-induced conformation change…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Using large-scale genomics data to identify driver mutations in lung cancer: methods and challenges by Hudson, Andrew M, Wirth, Christopher, Stephenson, Natalie L, Fawdar, Shameem, Brognard, John, Miller, Crispin J

    Published in Pharmacogenomics (01-07-2015)
    “…Lung cancer is the commonest cause of cancer death in the world and carries a poor prognosis for most patients. While precision targeting of mutated proteins…”
    Get full text
    Journal Article
  6. 6

    Somatically mutated ABL1 is an actionable and essential NSCLC survival gene by Testoni, Ewelina, Stephenson, Natalie L, Torres‐Ayuso, Pedro, Marusiak, Anna A, Trotter, Eleanor W, Hudson, Andrew, Hodgkinson, Cassandra L, Morrow, Christopher J, Dive, Caroline, Brognard, John

    Published in EMBO molecular medicine (01-02-2016)
    “…The lack of actionable mutations in patients with non‐small cell lung cancer (NSCLC) presents a significant hurdle in the design of targeted therapies for this…”
    Get full text
    Journal Article
  7. 7

    Improved Production and Biophysical Analysis of Recombinant Silicatein-α by Sparkes, Emily I, Kettles, Rachel A, Egedeuzu, Chisom S, Stephenson, Natalie L, Caslin, Stephanie A, Tabatabaei Dakhili, S Yasin, Wong, Lu Shin

    Published in Biomolecules (Basel, Switzerland) (20-08-2020)
    “…Silicatein-α is a hydrolase found in siliceous sea sponges with a unique ability to condense and hydrolyse silicon-oxygen bonds. The enzyme is thus of interest…”
    Get full text
    Journal Article
  8. 8

    Mutational analysis of the Notch2 negative regulatory region identifies key structural elements for mechanical stability by Stephenson, Natalie L., Avis, Johanna M.

    Published in FEBS open bio (01-01-2015)
    “…•Mutations within heterodimerization (HD) domain of Notch2 reduce mechanical stability.•Structural changes are observed within the LNRA:B linker region/LNRB…”
    Get full text
    Journal Article
  9. 9

    Protein kinase Cα gain-of-function variant in Alzheimer’s disease displays enhanced catalysis by a mechanism that evades down-regulation by Callender, Julia A., Yang, Yimin, Lordén, Gema, Stephenson, Natalie L., Jones, Alexander C., Brognard, John, Newton, Alexandra C.

    “…Conventional protein kinase C (PKC) family members are reversibly activated by binding to the second messengers Ca2+ and diacylglycerol, events that break…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Truncation- and motif-based pan-cancer analysis reveals tumor-suppressing kinases by Hudson, Andrew M, Stephenson, Natalie L, Li, Cynthia, Trotter, Eleanor, Fletcher, Adam J, Katona, Gitta, Bieniasz-Krzywiec, Patrycja, Howell, Matthew, Wirth, Chris, Furney, Simon, Miller, Crispin J, Brognard, John

    Published in Science signaling (17-04-2018)
    “…A major challenge in cancer genomics is identifying "driver" mutations from the many neutral "passenger" mutations within a given tumor. To identify driver…”
    Get more information
    Journal Article
  12. 12

    Abstract 4408: Mutant ABL1 is a genetic dependency in non-small cell lung cancer amenable to pharmacological intervention by Torres-Ayuso, PEDRO, Testoni, Ewelina, Stephenson, Natalie L., Marusiak, Anna A., Trotter, Eleanor W., Hudson, Andrew, Hodgkinson, Cassandra L., Morrow, Christopher J., Dive, Caroline, Brognard, John

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract Non-small cell lung cancer (NSCLC) is the most frequent lung cancer subtype and it affects near 1.5 million patients worldwide annually. The lack of…”
    Get full text
    Journal Article
  13. 13

    Protein kinase Ca gain-of-function variant in Alzheimer’s disease displays enhanced catalysis by a mechanism that evades down-regulation by Callender, Julia A, Yang, Yimin, Lordén, Gema, Stephenson, Natalie L, Jones, Alexander C, Brognard, John, Newton, Alexandra C

    “…Conventional protein kinase C (PKC) family members are reversibly activated by binding to the second messengers Ca2+ and diacylglycerol, events that break…”
    Get full text
    Journal Article
  14. 14

    Abstract 5270: Prevalence of inactivating protein kinase C mutations in human cancers by Antal, Corina E., Kang, Emily, Stephenson, Natalie L., Trotter, Eleanor W., Hunter, Tony, Brognard, John, Newton, Alexandra

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Abstract Protein kinase C (PKC) levels are aberrant in diverse cancers and over 400 mutations in PKC have been identified in human cancers. Here we…”
    Get full text
    Journal Article
  15. 15

    Abstract 125: Protein kinase C loss-of-function mutations in cancer reveal role as tumor suppressor by Antal, Corina E., Hudson, Andrew M., Kang, Emily, Zanca, Ciro, Wirth, Christopher, Stephenson, Natalie L., Trotter, Eleanor W., Gallegos, Lisa L., Miller, Crispin, Furnari, Frank, Hunter, Tony, Brognard, John, Newton, Alexandra C.

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…Abstract Protein kinase C (PKC) remains an elusive chemotherapeutic target despite decades of research. To determine whether PKC isozymes function as oncogenes…”
    Get full text
    Journal Article
  16. 16

    Somatically mutated ABL 1 is an actionable and essential NSCLC survival gene by Testoni, Ewelina, Stephenson, Natalie L, Torres‐Ayuso, Pedro, Marusiak, Anna A, Trotter, Eleanor W, Hudson, Andrew, Hodgkinson, Cassandra L, Morrow, Christopher J, Dive, Caroline, Brognard, John

    Published in EMBO molecular medicine (01-02-2016)
    “…Abstract The lack of actionable mutations in patients with non‐small cell lung cancer ( NSCLC ) presents a significant hurdle in the design of targeted…”
    Get full text
    Journal Article